Boston Scientific wins expanded FDA nod for cryoablation system
Boston Scientific (NYSE:BSX) announced today that it received expanded FDA 510(k) clearance for its Visual Ice cryoablation system.
Stay updated with breaking news from Peter Pattison. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Boston Scientific (NYSE:BSX) announced today that it received expanded FDA 510(k) clearance for its Visual Ice cryoablation system.
Boston Scientific (NYSE: BSX) announced that it received FDA 510(k) clearance for its Embold Soft & Packing coils.
Bruce Power announced on Monday that it is exploring the production of another type of cancer-fighting medical isotope.
Marlborough medical device manufacturer Boston Scientific Corp. has acquired Obsidio, Inc., a South Carolina-based medical materials developer.
Boston Scientific received FDA 510(k) clearance for the Embold fibered detachable coil for use in the peripheral vasculature.